Literature DB >> 15911797

[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.

A Siderowf1, A Newberg, K L Chou, M Lloyd, A Colcher, H I Hurtig, M B Stern, R L Doty, P D Mozley, N Wintering, J E Duda, D Weintraub, P J Moberg.   

Abstract

BACKGROUND: In vivo imaging of the dopamine transporter with [99mTc]TRODAT-1 (TRODAT) and olfactory testing have both been proposed as potential biomarkers in Parkinson disease (PD).
OBJECTIVE: To evaluate the relationship between TRODAT SPECT imaging, odor identification skills, and motor function in patients with early PD.
METHODS: Twenty-four patients with a clinical diagnosis of early-stage PD (mean Hoehn & Yahr stage = 1.4) underwent TRODAT imaging, Unified PD Rating Scale (UPDRS) ratings of motor function, and administration of the University of Pennsylvania Smell Identification Test (UPSIT). Brain images were obtained using a standardized processing protocol and specific uptake ratios for striatal regions of interest were calculated. Partial correlations between the imaging indices, disease duration, UPSIT scores, and UPDRS motor scores were then calculated.
RESULTS: UPSIT scores were correlated with TRODAT uptake in the striatum as a whole (r = 0.66, p = 0.001). The putamen showed the strongest correlation with the UPSIT (r = 0.74; p < 0.001). The correlation between dopamine transporter density in the caudate and UPSIT was moderate (r = 0.36, p = 0.11), but was not significant.
CONCLUSIONS: Olfactory function is highly correlated with dopamine transporter imaging abnormalities in early Parkinson disease (PD). Further studies are warranted to determine whether changes over time in these two measures are also correlated in early PD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911797     DOI: 10.1212/01.WNL.0000161874.52302.5D

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  44 in total

Review 1.  Early diagnosis of Parkinson's disease.

Authors:  Jörg Spiegel; Alexander Storch; Wolfgang H Jost
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

2.  Olfactory dysfunction in LRRK2 G2019S mutation carriers.

Authors:  R Saunders-Pullman; K Stanley; C Wang; M San Luciano; V Shanker; A Hunt; L Severt; D Raymond; L J Ozelius; R B Lipton; S B Bressman
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

3.  Depression rating scales in Parkinson's disease: critique and recommendations.

Authors:  Anette Schrag; Paolo Barone; Richard G Brown; Albert F G Leentjens; William M McDonald; Sergio Starkstein; Daniel Weintraub; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

4.  Odor identification and progression of parkinsonian signs in older persons.

Authors:  Robert S Wilson; Steven E Arnold; Aron S Buchman; Yuxiao Tang; David A Bennett
Journal:  Exp Aging Res       Date:  2008 Jul-Sep       Impact factor: 1.645

Review 5.  Neuroprotection in Parkinson's disease: myth or reality?

Authors:  Tiffini Voss; Bernard Ravina
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

6.  Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.

Authors:  Guangwei Du; Mechelle M Lewis; Christopher Sica; Lu He; James R Connor; Lan Kong; Richard B Mailman; Xuemei Huang
Journal:  Mov Disord       Date:  2018-05-14       Impact factor: 10.338

7.  Taste function in early stage treated and untreated Parkinson's disease.

Authors:  Richard L Doty; Michael T Nsoesie; Inna Chung; Allen Osman; Ian Pawasarat; Julie Caulfield; Howard Hurtig; Jonathan Silas; Jacob Dubroff; John E Duda; Gui-Shuang Ying; Hakan Tekeli; Fidias E Leon-Sarmiento
Journal:  J Neurol       Date:  2014-12-06       Impact factor: 4.849

8.  Association of anosmia with autonomic failure in Parkinson disease.

Authors:  David S Goldstein; LaToya Sewell; Courtney Holmes
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

Review 9.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

10.  Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.

Authors:  Rui Liu; David M Umbach; Alexander I Tröster; Xuemei Huang; Honglei Chen
Journal:  Parkinsonism Relat Disord       Date:  2020-02-11       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.